Allakos Inc.

NAS: ALLK

GO
/marketstate/country/us

After Hours

 --Real time quotes

Feb 8, 2023, 4:04 p.m.

/zigman2/quotes/203639566/composite

$

6.96

Change

+0.08 +1.16%

Volume

Volume 13,903

Real time quotes

/zigman2/quotes/203639566/composite

Today's close

$ 7.29

$ 6.88

Change

-0.41 -5.62%

Day low

Day high

$6.78

$7.28

Open

52 week low

52 week high

$2.54

$8.73

Open

Insider Actions for Allakos Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/06/2023 Robert Alexander
Chief Executive Officer; Director
301,575   Award at $0 per share. 0
01/06/2023 Adam L. Tomasi
President
195,997   Award at $0 per share. 0
01/06/2023 Harlan Baird Radford
Chief Financial Officer
126,640   Award at $0 per share. 0
01/06/2023 Craig Paterson
Chief Medical Officer
102,690   Award at $0 per share. 0
12/02/2022 Robert Alexander
Chief Executive Officer; Director
15,152   Derivative/Non-derivative trans. at $8.11 per share. 122,882
12/02/2022 Adam L. Tomasi
President
9,783   Derivative/Non-derivative trans. at $8.11 per share. 79,340
12/02/2022 Harlan Baird Radford
Chief Financial Officer
3,843   Derivative/Non-derivative trans. at $8.11 per share. 31,166
12/02/2022 Craig Paterson
Chief Medical Officer
4,863   Derivative/Non-derivative trans. at $8.11 per share. 39,438
09/21/2022 Alta Partners Management Corp.
Director
475,000   Acquisition at $5.02 per share. 2,384,500
09/21/2022 NEA Management Co. LLC
Director
3,386,400   Acquisition at $5.02 per share. 16,999,728
09/21/2022 NEA Management Co. LLC
Director
597,600   Acquisition at $5.02 per share. 2,999,952
09/02/2022 Robert Alexander
Chief Executive Officer; Director
8,316   Derivative/Non-derivative trans. at $4.54 per share. 37,754
09/02/2022 Adam L. Tomasi
President
5,369   Derivative/Non-derivative trans. at $4.54 per share. 24,375
09/02/2022 Harlan Baird Radford
Chief Financial Officer
585   Derivative/Non-derivative trans. at $4.54 per share. 2,655
09/02/2022 Craig Paterson
Chief Medical Officer
1,129   Derivative/Non-derivative trans. at $4.54 per share. 5,125
09/02/2022 Margaret Fitzgerald
General Counsel and Secretary
335   Derivative/Non-derivative trans. at $4.54 per share. 1,520
06/02/2022 Robert Alexander
Chief Executive Officer; Director
8,084   Derivative/Non-derivative trans. at $2.75 per share. 22,231
06/02/2022 Adam L. Tomasi
President
5,219   Derivative/Non-derivative trans. at $2.75 per share. 14,352
06/02/2022 Harlan Baird Radford
Chief Financial Officer
2,274   Derivative/Non-derivative trans. at $2.75 per share. 6,253
06/02/2022 Craig Paterson
Chief Medical Officer
226   Derivative/Non-derivative trans. at $2.75 per share. 621
06/02/2022 Margaret Fitzgerald
General Counsel and Secretary
318   Derivative/Non-derivative trans. at $2.75 per share. 874
04/19/2022 Margaret Fitzgerald
General Counsel and Secretary
57,637   Award at $0 per share. 0
03/02/2022 Robert Alexander
Chief Executive Officer; Director
8,215   Derivative/Non-derivative trans. at $5.38 per share. 44,196
03/02/2022 Adam L. Tomasi
President
5,582   Derivative/Non-derivative trans. at $5.38 per share. 30,031
03/02/2022 Mark A. Asbury
CLO
1,680   Derivative/Non-derivative trans. at $5.38 per share. 9,038
02/25/2022 Robert Alexander
Chief Executive Officer; Director
529,323   Award at $0 per share. 0
02/25/2022 Adam L. Tomasi
President
344,060   Award at $0 per share. 0
02/25/2022 Harlan Baird Radford
Chief Financial Officer
237,608   Award at $0 per share. 0
02/25/2022 Mark A. Asbury
CLO
140,490   Award at $0 per share. 0
12/02/2021 Robert Alexander
Chief Executive Officer; Director
20,241   Derivative/Non-derivative trans. at $78.69 per share. 1,592,764
12/02/2021 Adam L. Tomasi
President
13,067   Derivative/Non-derivative trans. at $78.69 per share. 1,028,242
12/01/2021 Robert Alexander
Chief Executive Officer; Director
51,681   Award at $0 per share. 0
12/01/2021 Adam L. Tomasi
President
33,362   Award at $0 per share. 0
12/01/2021 Harlan Baird Radford
Chief Financial Officer
24,255   Award at $0 per share. 0
12/01/2021 Mark A. Asbury
CLO
26,003   Award at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
4 Purchases
4 Sales
726,902
33,641
Last 6 months
7 Purchases
9 Sales
5,185,902
49,375
Last 12 months
12 Purchases
17 Sales
6,495,020
80,973

Officers and Executives

Dr. Robert Alexander
Chief Executive Officer & Director
Dr. Adam L. Tomasi
President & Chief Operating Officer
Mr. Harlan Baird Radford
Chief Financial Officer
Dr. Ruby Casareno
Vice President-Technical Operations
Dr. Craig Paterson
Chief Medical Officer
Mr. Roland K. Winger
Senior Vice President
Dr. Amy L. Ladd
Director
Dr. Sally D. Bolmer
Vice President-Regulatory Affairs & Development
Mr. Alex Schwartz
Vice President-Investor Relations
Mr. Daniel S. Janney
Chairman
Dr. John P. McKearn
Independent Director
Mr. Steven P. James
Independent Director
Mr. Paul E. Walker
Independent Director
Mr. Robert E. Andreatta
Independent Director
Link to MarketWatch's Slice.